The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
AVATAXHER: An open-label, randomized, multicenter study investigating the addition of bevacizumab (B) to neoadjuvant trastuzumab (T) plus docetaxel (D) in patients with early stage HER2-positive breast cancer (HER2+ BC) stratified according to PET change after one therapy cycle.
Bruno P. Coudert
Consultant or Advisory Role - Genomic Health; Pfizer; Roche
Honoraria - Amgen; Roche
Other Remuneration - GlaxoSmithKline; Lilly; Roche
Jean-Yves Pierga
Consultant or Advisory Role - Roche (U)
Honoraria - Roche
Research Funding - Roche
Marie-Ange Mouret-Reynier
No relevant relationships to disclose
Khaldoun Kerrou
Research Funding - Roche
Jean-Marc Ferrero
No relevant relationships to disclose
Thierry Petit
Consultant or Advisory Role - Roche
Honoraria - Roche
Pierre Kerbrat
No relevant relationships to disclose
Pierre-Francois Dupre
No relevant relationships to disclose
Thomas Denis Bachelot
Consultant or Advisory Role - Roche
Research Funding - Roche
Philippe Gabelle
No relevant relationships to disclose
Sylvia Giard
Consultant or Advisory Role - Roche (U)
Expert Testimony - Surgery (U)
David Coeffic
Honoraria - Roche
Philippe Bougnoux
No relevant relationships to disclose
Jean Briac Prevost
No relevant relationships to disclose
Gilles Paintaud
Research Funding - Roche
Gilles Thibault
Research Funding - Roche
Juana Hernandez
Employment or Leadership Position - Roche
Mathieu Coudert
Employment or Leadership Position - Roche
Laurent Arnould
Consultant or Advisory Role - Roche
Honoraria - Roche
Other Remuneration - Roche
Alina Berriolo-Riedinger
No relevant relationships to disclose